| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |